Refine Search
(0)
(1)
(6)
(6)

Growing Burden of Age-Related Macular Edema

According to GlobalData’s epidemiological forecast, the total prevalent cases of AMD—which is made up of individuals who have been diagnosed with the disease and are receiving treatment, as well as those who have not been diagnosed—in the seven major markets will increase to 82,997,296 cases in 2026. In light of the expected increase in total prevalent cases of AMD due to the growing ageing population, further research to garner a better understand of the nature of AMD will be critical to tackle the burden of the disease.

Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2026

  • $10,995
  • February 2018
Add to Basket Quick View Add to Saved List

There are two clinical forms of age-related macular degeneration (AMD): dry and wet. Currently there are therapies available only for wet AMD. Drugs in late stages of development target the wet AMD segment and the late stage or atrophic form of...

EpiCast Report: Glaucoma – Epidemiology Forecast to 2026

  • $3,995
  • December 2017
Add to Basket Quick View Add to Saved List

Glaucoma is a common, asymptomatic group of eye diseases that causes damage to the eye’s optic nerve, resulting in progressive, irreversible vision loss. Glaucoma is one of the leading causes of blindness worldwide, especially in elderly people...

PharmaPoint: Macular Edema – Global Drug Forecast and Market Analysis to 2026

  • $10,995
  • November 2017
Add to Basket Quick View Add to Saved List

ME is a condition characterized by the thickening and swelling (edema) of the macula, which is the area of the retina that is responsible for central vision. The occurrence of ME is highly frequent in diabetics and usually manifests itself as D...

OpportunityAnalyzer: Uveitis Opportunity Analysis and Forecasts to 2026

  • $10,995
  • November 2017
Add to Basket Quick View Add to Saved List

Uveitis is an inflammatory condition of the eye affecting mainly the uvea. It encompasses a heterogeneous collection of disorders characterized by ocular inflammation. Currently, there is only a limited number of approved drugs for the treatmen...

EpiCast Report: Macular Edema – Epidemiology Forecast to 2026

  • $3,995
  • November 2017
Add to Basket Quick View Add to Saved List

Macular edema (ME) is a condition characterized by the thickening and swelling (edema) of the macula, which is the area of the retina that is responsible for central vision. The occurrence of ME is highly frequent in diabetics and usually manif...

EpiCast Report: Age-Related Macular Degeneration – Epidemiology Forecast to 2026

  • $3,995
  • November 2017
Add to Basket Quick View Add to Saved List

Age-related macular degeneration (AMD) is a progressive eye condition that is characterized by the gradual deterioration of the macula, which is the area of the retina responsible for central vision. AMD is the most common cause of significant ...